CALUMET SPECIALTY PRODS PTNR's ticker is CLMT and the CUSIP is 131476103. A total of 71 filers reported holding CALUMET SPECIALTY PRODS PTNR in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $315,110 | +8.4% | 16,498 | -10.0% | 0.00% | -100.0% |
| Q2 2023 | $290,729 | -18.1% | 18,331 | -10.2% | 0.00% | 0.0% |
| Q1 2023 | $354,933 | +0.5% | 20,422 | -2.6% | 0.00% | 0.0% |
| Q4 2022 | $353,324 | -10.3% | 20,961 | -31.9% | 0.00% | 0.0% |
| Q3 2022 | $394,000 | +97.0% | 30,763 | +59.7% | 0.00% | – |
| Q2 2022 | $200,000 | +25.0% | 19,260 | +63.3% | 0.00% | – |
| Q1 2022 | $160,000 | +29.0% | 11,796 | +24.6% | 0.00% | – |
| Q4 2021 | $124,000 | +51.2% | 9,467 | -9.3% | 0.00% | – |
| Q3 2021 | $82,000 | +13.9% | 10,443 | -0.0% | 0.00% | – |
| Q2 2021 | $72,000 | +12.5% | 10,448 | -0.3% | 0.00% | – |
| Q1 2021 | $64,000 | +93.9% | 10,478 | -3.3% | 0.00% | – |
| Q4 2020 | $33,000 | -5.7% | 10,838 | -17.7% | 0.00% | – |
| Q3 2020 | $35,000 | +12.9% | 13,163 | -5.4% | 0.00% | – |
| Q2 2020 | $31,000 | +121.4% | 13,913 | -1.5% | 0.00% | – |
| Q1 2020 | $14,000 | – | 14,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evermore Global Advisors, LLC | 1,672,349 | $22,761,000 | 28.09% |
| Knott David M Jr | 4,392,500 | $59,782,000 | 19.04% |
| Adams Asset Advisors, LLC | 5,224,715 | $71,108,000 | 10.45% |
| Barnett & Company, Inc. | 306,582 | $4,173,000 | 2.96% |
| Springhouse Capital Management, LP | 209,139 | $2,846,000 | 1.81% |
| Bienville Capital Management, LLC | 252,814 | $3,441,000 | 1.69% |
| Windsor Wealth Management, Inc. | 120,878 | $1,582,000 | 0.29% |
| Column Capital Advisors, LLC | 65,000 | $885,000 | 0.16% |
| Linscomb & Williams, Inc. | 144,274 | $1,964,000 | 0.09% |
| Future Financial Wealth Managment LLC | 8,000 | $109,000 | 0.09% |